High-density lipoprotein: A novel marker for risk of in-hospital infection in acute ischemic stroke patients?

Cerebrovascular Diseases

Volumn 35, Issue 3, 2013, Pages 291-297

  Rodríguez Sanz, Ana ^a   Fuentes, Blanca ^a   Martínez Sánchez, Patricia ^a   Prefasi, Daniel ^a   Martínez Martínez, Marta ^a   Correas, Elisa ^a   Díez Tejedor, Exuperio ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

High density lipoprotein cholesterol; In hospital complications; Infection; Stroke

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PNEUMONIA; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEPSIS; URINARY TRACT INFECTION;

EID: 84876081616     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000347077     Document Type: Article

References (39)

1. Ionita CC, Siddiqui AH, Levy EI, Hopkins LN, Snyder KV, Gibbons KJ: Acute ischemic stroke and infections. J Stroke Cerebrovasc Dis 2011; 20: 1-9
2. Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG, van de Beek D: Post-stroke infection: A systematic review and meta-analysis. BMC Neurol 2011; 11: 110
3. Meisel A, Meisel C, Harms H, Hartman O, Ulm L: Predicting post-stroke infections and outcome with blood-based immune and stress markers. Cerebrovasc Dis 2012; 33: 580-588
4. Kumar S, Selim MH, Caplan LR: Medical complications after stroke. Lancet Neurol 2010; 9: 105-118
5. Hug A, Dalpke A, Wieczorek N, Giese T, Lorenz A, Auffarth G, Liesz A, Veltkamp R. Infarct volume is a major determiner of poststroke immune cell function and susceptibility to infection. Stroke 2009; 40; 3226-3232
6. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM: High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection. Circulation 2001; 103: 2283-2288
7. Gazi IF, Apostolou FA, Liberopoulos EN, Filippatos TD, Tellis CC, Elisaf MS, Tselepis AD: Leptospirosis is associated with markedly increased triglycerides and small dense low-density lipoprotein and decreased highdensity lipoprotein. Lipids 2011; 46: 953-960
8. Apostolou F, Gazi IF, Kostoula A, Tellis CC, Tselepis AD, Elisaf M, Liberopoulos EN: Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella J Lipid Res 2009; 50: 2532-2539
9. Luthold S, Berneis K, Bady P, Muller B: Effects of infectious disease on plasma lipids and their diagnostic significance in critical illness. Eur J Clin Invest 2007; 37: 573-579
10. Gordon SM, Hofmann S, Askew DA, Davidson WS: High-density lipoprotein: it's not just about lipid transport anymore. Trends Endocrinol Metab 2011; 22: 9-15
11. Villarroel F, Bastias A, Casado A, Amthauer R, Concha MI: Apolipoprotein A-I, an antimicrobial protein in Oncorhynchus mykiss : evaluation of its expression in primary defence barriers and plasma levels in sick and healthy fish. Fish Shellfish Immunol 2007; 23: 197-209
12. Caipanq CM, Hynes N, Puanqkaew J, Brinchmann MF, Kiron V: Intraperitoneal vaccination of Atlantic cod, Gadus morhua with heatkilled Listonella anguillarum enhances serum antibacterial activity and expression of immune response genes. Fish Shellfish Immunol 2008; 24: 314-322
13. Grunfeld C, Feingold KR: HDL and innate immunity: A tale of two apolipoproteins. J Lipid Res 2008; 49: 1605-1606
14. Yu BL, Wang SG, Peng DQ, Zhao SP: HDL and immunomodulation: An emerging role of HDL against atherosclerosis. Immunol Cell Biol 2012; 88: 285-290
15. Haas MJ, Mooradian AD: Regulation of highdensity lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease. Diabetes Metab Res Rev 2010; 26: 90-99
16. Delgado-Rodriguez M, Medina-Cuadros M, Martinez-Gallego G, Sillero-Arenas M: Total cholesterol, HDL cholesterol and risk of nosocomial infection: A prospective study in surgical patients. Infect Control Hosp Epidemiol 1997; 18: 9-18
17. Canturk NZ, Canturk Z, Okay E, Yirmibesoglu O, Eraldemir B: Risk of nosocomial infections and effects of total cholesterol, HDL cholesterol in surgical patients. Clin Nutr 2002; 21: 431-436
18. Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, Friger M, Danon A: Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 2004; 110: 880-885
19. Chua D, Tsang RS, Kuo IF: The role of statin therapy in sepsis. Ann Pharmacother 2007; 41: 647-652
20. Montaner J, Chacon P, Krupinski J, Rubio F, Millan M, Molina CA, Hereu P, Quintana M, Alvarez-Sabin J: Simvastatin in the acute phase of ischemic stroke: A safety and efficacy pilot trial. Eur J Neurol 2008; 15: 82-90
21. Bogousslavsky J, van Melle G, Regli F: The Lausanne Stroke Registry: Analysis of 1,000 consecutive patients with first stroke. Stroke 1988; 19: 1083-1092
22. Arboix A, Alvarez-Sabin J, Soler L: Stroke. Classification and diagnostic criteria. Ad hoc Editorial Committee of the Task Force on Cerebrovascular Diseases of SEN. Neurologia 1998; 13: 3-10
23. Hackam DG, Mamdani M, Li P, Redelmeier DA: Statins and sepsis in patients with cardiovascular disease: A population-based cohort analysis. Lancet 2006; 367: 413-418
24. Rodriguez de Antonio LA, Martinez-Sanchez P, Martinez-Martinez MM, Cazorla-Garcia R, Sanz-Gallego I, Fuentes B, Diez-Tejedor E: Previous statins treatment and risk of poststroke infections. Neurologia 2011; 26: 150-156
25. Yeh PS, Lin HJ, Chen PS, Lin SH, Wang WM, Yang CM, Li YH: Effect of statin treatment on three-month outcomes in patients with stroke-associated infection: A prospective cohort study. Eur J Neurol 2012; 19: 689-695
26. Blank N, Schiller M, Krienke S, Busse F, Schätz B, Ho AD, Kalden JR, Lorenz HM: Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis. J Immunol 2007; 179: 3613-3621
27. Fuentes B, Díez-Tejedor E, Ortega-Casarrubios MA, Martínez P, Lara M, Frank A: Consistency of the benefits of stroke units over years of operation: An 8-year effectiveness analysis. Cerebrovasc Dis 2006; 21: 173-179
28. Alvarez-Sabín J, Ribó M, Masjuan J, Tejada JR, Quintana M, Investigadores del Estudio PRACTIC: Hospital care of stroke patients: importance of expert neurological care. Neurologia 2011; 26: 510-517
29. González MJ, Falip R, Martín R, Matías-Guiu J: A comparative study of mortality and infectious complications in patients admitted to neurological and general wards. Rev Neurol 1995; 23: 385-389
30. Govan L, Langhorne P, Weir CJ: Does the prevention of complications explain the survival benefit of organized inpatient (stroke unit) care? Further analysis of a systematic review. Stroke 2007; 38: 2536-2540
31. Indredavik B, Fjaertoft H, Ekeberg G, Løge AD, Mørch B: Benefit of an extended stroke unit service with early supported discharge: A randomized, controlled trial. Stroke 2000; 31: 2989-2994
32. Fjaertoft H, Indredavik B, Lydersen S: Stroke unit care combined with early supported discharge: long-term follow-up of a randomized controlled trial. Stroke 2003; 34: 2687-2691
33. Roth JE, Lovell L, Harvey RL, Heiemann AW, Semik P, Diaz S: Incidence of and risk factors for medical complications during stroke rehabilitation. Stroke 2001; 32: 523-529
34. Indredavik B, Rohweder G, Naalsund E, Lydersen S: Medical complications in a comprehensive stroke unit and an early supported discharge service. Stroke 2008; 39: 414-420
35. Langhorne P, Stott DJ, Roberson L, MacDonald J, Jones L, McAlpine C, Dick F, Taylor GS, Murray G: Medical complications after stroke: A multicenter study. Stroke 2000; 31: 1223-1229
36. Kalra L, Yu G, Wilson K, Roots P: Medical complications during stroke rehabilitation. Stroke 1995; 26: 990-994
37. Davenport RJ, Dennis MS, Welwood I, Warlow C: Complications after acute stroke. Stroke 1996; 27: 415-420
38. Minnerup J, Schäbitz WR: Improving outcome after stroke: time to treat new targets. Stroke 2012; 43: 295-296
39. Martínez-Sánchez P, Fuentes B, Medina-Báez J, Grande M, Llorente C, Parrilla P, Fuster A, Gil A, Sánchez M, Olguín C, García-Caballero J, Díez-Tejedor E: Development of an acute stroke care pathway in a hospital with stroke unit. Neurologia 2010; 25: 17-26.